Prof. Terence Kee, Singapore
Impact of mRNA COVID-19 vaccination on clinical outcomes of COVID-19 infection in kidney transplant recipients at the Singapore General Hospital
Miss Constance Chui Wan Lee, Singapore
Safe living kidney donor transplantation during the COVID-19 Pandemic - Experience from the Singapore General Hospital
Dr. Amy Chang, United States
Differential Immunogenicity of mRNA-1273 versus BNT162b2 as a Third Vaccine Dose for Solid Organ Transplant Recipients Seronegative after Two BNT162b2 Doses
Dr. Hailey J Hardgrave, United States
Undetectable Recipient COVID-19 Plasma PCR Following COVID-19 Positive Donor Kidney Transplant: Proof of Concept Analysis
Mr. Lawrence Suplee, United States
Timely lower respiratory SARS-CoV-2 testing of all potential organ donors leads to successful transplantation of organs from SARS-CoV-2+ donors
Dr. Alfredo Chew-Wong, Mexico
Seroconversion after vaccination with BNT162b2 Pfizer/BioNTech, ChAdOx1 nCoV-19/AZD1222 and coronavac against sars-cov-2 among hemodialysis and kidney transplant patients
Dr. Olga Caporale, Italy
Humoral response to COVID-19 mRNA vaccines in a cohort of young kidney transplant recipients from a single Center in Northern Italy
Dr. Ahram Han, Korea
Antibody response to booster mRNA COVID-19 vaccine after standard doses of various homologous and heterologous vaccines in Kidney Transplant Recipients